The EC approved the CAR T-cell therapy based on data from a Phase II study showing a 94 percent complete response rate.

Crizanlizumab (Adakveo) failed to outperform placebo in patients with sickle cell disease, the phase III STAND trial showed.

A European business lobby group urged China to take steps not to prioritise low prices over product safety in the country's ...

Joseph Borzelleca published a study on the food coloring Red No. 3. The FDA cited his work when banning the additive in ...

The decision was supported by a randomised, six-week, placebo-controlled trial involving 316 adolescent subjects.

Geron Corporation (Nasdaq: GERN), a commercial-stage biopharmaceutical company aiming to change lives by changing the course of blood cancer, today an ...

AstraZeneca and Ionis Pharmaceuticals’ polyneuropathy drug has won approval in the European Union (EU), where it will be marketed as Wainzua (eplontersen). The drug has been approved to treat ...

Leqembi’s application now moves forward to the European Commission, which will issue a formal verdict for the injection that ...

As we observe Rare Disease Day today, let us take a look at seven drugs poised to be approved to address rare diseases in ...

The European Union’s medicines regulator on Friday reiterated its positive recommendation for Eisai and Biogen’s Alzheimer’s ...

This approval marks the first chikungunya vaccine authorized in Europe for this age group and follows the U.S. Food and Drug Administration’s approval earlier in the month. Bavarian Nordic plans to ...

Krystal Biotech (KRYS) has received a positive recommendation from EU regulators for its drug Vyjuvek for the treatment of wounds in patients with dystrophic epidermolysis bullosa.